
In this episode of the Psychedelic Spotlight podcast, we catch up with Ronan Levy, Co-Founder and Executive Chairman of Field Trip Health.
In this episode of the Psychedelic Spotlight podcast, we catch up with Ronan Levy, Co-Founder and Executive Chairman of Field Trip Health.
July 21, 2021- This week’s Psychedelic Business News top stories…
Psychedelic Decriminalization Update Today, we take a look at 3…
MindMed (MMED :NEO), (MNMD:NASDAQ), (MMQ: FRA) is testing the delivery of psychedelics compounds directly to the brain!?
What is the best way to take a psychedelic medicine? Is it in a format of a pill, a film strip which dissolves under the tongue, or maybe an injection? These are the standard delivery methods we’re all familiar with.
But what if we could deliver a psychedelic medicine directly to the brain, and thus negate any potentially negative side effects of the drug interacting with the body?
Answering this question is the purpose of a new MindMed partnership.
In this episode, we’ll explore MindMed’s new partnership with Nextage Therapeutics, their Brain Targeting Liposome System (BTLS), and it’s applications.
Enjoy the episode!
Link:
https://mindmed.co/news/press-release/mindmed-announces-launch-of-collaboration-with-nextage-therapeutics-brain-targeting-liposome-system/
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @thepsychedelicinvestor
Email: thepsychedelicinvestor@gmail.com
Facebook: @thepsychedelicinvestor
Website: https://thepsychedelicinvestor.com/
Music: www.bensound.com
Video editing: @themyaholy
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#MindMed #MNMD #MindmedNews
We debut our first ever “Ask a Psychotherapist” segment where we take questions submitted by our listeners and have Kelli Foulkrod, a transpersonal psychotherapist, answer them.
In this interview, David Flores sits down with Cody Shandraw,…
We speak with Anthony Tennyson, CEO of Awakn Life Sciences, a biotechnology company with clinical operations developing and delivering psychedelic medicine to treat addiction.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
Notifications